Dextran 40 in 0.9% Sodium Chloride Disease Interactions
There are 4 disease interactions with Dextran 40 in 0.9% Sodium Chloride (dextran, low molecular weight).
Dextran (applies to Dextran 40 in 0.9% Sodium Chloride) cardiac failure
Major Potential Hazard, Moderate plausibility. Applicable conditions: Heart Disease
Low molecular weight and high molecular weight dextran is contraindicated in patients with marked cardiac decompensation.
Dextran (applies to Dextran 40 in 0.9% Sodium Chloride) hemostatic defects
Major Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect, Thrombocytopenia
The use of dextran is contraindicated in patients with marked hemostatic defects of all types (thrombocytopenia, hypofibrinogenemia, etc.) including those caused by drugs such as heparin, warfarin, etc.
Dextran (applies to Dextran 40 in 0.9% Sodium Chloride) renal impairment
Major Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Low molecular and high molecular weight dextran are contraindicated in patients with renal disease with severe oliguria or anuria.
Dextran (applies to Dextran 40 in 0.9% Sodium Chloride) bleeding
Moderate Potential Hazard, Moderate plausibility.
Caution should be employed when using dextran (low and high molecular weight) in patients with active hemorrhage as the resulting increase in perfusion pressure and improved microcirculatory flow may result in additional blood loss.
Switch to professional interaction data
Dextran 40 in 0.9% Sodium Chloride drug interactions
There are 33 drug interactions with Dextran 40 in 0.9% Sodium Chloride (dextran, low molecular weight).
Report options
More about Dextran 40 in 0.9% Sodium Chloride (dextran, low molecular weight)
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: plasma expanders
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Eliquis
Eliquis (apixaban) is used to reduce the risk of stroke and systemic embolism in patients with ...
Medrol
Medrol is used for allergic rhinitis, asthma, asthma, acute, asthma, maintenance, congenital ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Epinephrine
Epinephrine (adrenaline) Injection is used to treat severe allergic reactions (anaphylaxis) to ...
Hydrocortisone
Hydrocortisone systemic is used for addison's disease, adrenocortical insufficiency, asthma, acute ...
Apixaban
Apixaban systemic is used for deep vein thrombosis, deep vein thrombosis prophylaxis after hip ...
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Methylprednisolone
Methylprednisolone is used to treat conditions such as allergies, arthritis, lupus and ulcerative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.